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Abstract
Background: Human pluripotent stem cells (hPSCs) are being applied in regenerative medicine and for the in vitro
modeling of human intractable disorders. In particular, neural cells derived from disease-specific human induced
pluripotent stem cells (hiPSCs) established from patients with neurological disorders have been used as in vitro disease
models to recapitulate in vivo pathogenesis because neural cells cannot be usually obtained from patients themselves.
Results: In this study, we established a rapid, efficient, and simple method for efficiently deriving motor neurons from
hPSCs that is useful for pathophysiological analysis and the development of drugs to treat motor neuron diseases.
Treatment with GSK3β inhibitors during the initial phase of differentiation in combination with dual SMAD inhibition
was sufficient to induce PAX6+ and SOX1+ neural progenitors within 1 week, and subsequent treatment with retinoic
acid (RA) and purmorphamine, which activates sonic hedgehog (SHH) signaling, resulted in the highly efficient
induction of HB9+ and ISL-1+ motor neurons within 2 weeks. After 4 weeks of monolayer differentiation in motor
neuron maturation medium, hPSC-derived motor neurons were shown to mature, displaying larger somas and clearer
staining for the mature motor neuron marker choline acetyltransferase (ChAT). Moreover, hPSC-derived motor neurons
were able to form neuromuscular junctions with human myotubes in vitro and induced acetylcholine receptor (AChR)
clustering, as detected by Alexa 555-conjugated α-Bungarotoxin (α-BTX), suggesting that these hPSC-derived motor
neurons formed functional contacts with skeletal muscles. This differentiation system is simple and is reproducible in
several hiPSC clones, thereby minimizing clonal variation among hPSC clones. We also established a system for
visualizing motor neurons with a lentiviral reporter for HB9 (HB9e438::Venus). The specificity of this reporter was
confirmed through immunocytochemistry and quantitative RT-PCR analysis of high-positive fractions obtained via
fluorescence-activated cell sorting (FACS), suggesting its applicability for motor neuron-specific analysis.
Conclusions: Our motor neuron differentiation system and lentivirus-based reporter system for motor neurons
facilitate the analysis of disease-specific hiPSCs for motor neuron diseases.
Keywords: Human embryonic stem cells, Human induced pluripotent stem cells, Motor neurons, Long-term culture of
motor neurons, Lentiviral reporter
* Correspondence: hidokano@a2.keio.jp; yohei@aichi-med-u.ac.jp
2Department of Physiology, Keio University School of Medicine, Tokyo
160-8582, Japan
1Department of Neurology, Aichi Medical University School of Medicine,
Aichi 480-1195, Japan
Full list of author information is available at the end of the article
© 2015 Shimojo et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Shimojo et al. Molecular Brain  (2015) 8:79 
DOI 10.1186/s13041-015-0172-4
Background
Human pluripotent stem cells (hPSCs), including human
embryonic stem cells (hESCs) and human induced pluri-
potent stem cells (hiPSCs), can be differentiated into all
cell types of the human body and have been applied in
regenerative medicine and the pathophysiological ana-
lysis of intractable disorders [1]. In particular, neural
cells derived from disease-specific hiPSCs from patients
with neurological disorders have been especially useful
as in vitro disease models recapitulating in vivo patho-
genesis, as cells in the nervous system cannot be usually
obtained from patients themselves.
Amyotrophic lateral sclerosis (ALS), spinal muscular
atrophy (SMA), and spinal and bulbar muscular atrophy
(SBMA) are motor neuron diseases. Although these
motor neuron diseases exhibit different molecular path-
ologies, they share a common phenotype: motor neuron
degeneration. To reveal the mechanisms underlying
motor neuron degeneration and to develop novel drugs,
researchers have taken advantage of motor neurons de-
rived from disease-specific hiPSCs for pathological ana-
lysis [2–4]. However, the methods reported for motor
neuron derivation from hPSCs in previous studies are
time-consuming and require complicated manipulations.
Moreover, the efficiency of these methods tends to be
low, and show variability depending on hPSC clones re-
ferred to as clonal variations [5].
In this study, we established a simple, rapid, and re-
producible method for efficiently deriving motor neu-
rons from hPSCs without the transduction of any
exogenous genes. This method facilitates simple and ac-
curate pathophysiological analysis of motor neuron dis-
eases using disease-specific hiPSCs.
Results
Rapid and efficient motor neuron differentiation from
human pluripotent stem cells
By modifying our previously established method for de-
riving neural stem/progenitor cells (NS/PCs) as neuro-
spheres from hPSCs through embryoid body (EB)
formation [6, 7], we established a rapid neural differenti-
ation protocol from hPSCs (Fig. 1a). Because the deriv-
ation of NS/PCs from EBs using the previously
established method takes 1 month, we first utilized dual
SMAD inhibition to facilitate the neural differentiation
of EBs [8]. KhES1 human embryonic stem cells [9] were
detached from the feeder layer en bloc and cultured in
suspension to form EBs using a BMP inhibitor (3 μM
dorsomorphin) and a TGFβ inhibitor (3 μM SB4315342)
during the first three days of differentiation (DS) (from
day 1 to day 4). Although this dual SMAD inhibition
slightly increased the expression of neural markers
(PAX6 and SOX1) compared with untreated control
cells, it was not sufficient to derive neural progenitors
from EBs within two weeks of differentiation (Fig. 1b).
Thus, to further facilitate neural differentiation, we
added the GSK3β inhibitor (3 μM (2′Z, 3′E)-6-bromoin-
dirubin-3′-oxime (BIO)) during the same period, in
addition to dual SMAD inhibition (DSB). As a result, on
day 8, the expression of PAX6 and SOX1 was signifi-
cantly increased compared with control cells, by 3.7 ±
0.4-fold and 138 ± 34-fold, respectively (Fig. 1b). More-
over, the expression of the proneural gene NGN2 was in-
creased by 68 ± 16-fold after 14 days of differentiation
compared with untreated control cells. These results
suggest that GSK3β inhibition has a positive effect on
the neural differentiation of hESCs in our differentiation
system, possibly by activating the canonical Wnt path-
way through β-catenin. To drive differentiation into
motor neurons, we added retinoic acid (RA) (from day 2
of EB formation) and purmorphamine, which activates
the sonic hedgehog (SHH) signaling pathway (from day
4 of EB formation), to confer caudal and ventral regional
identities, respectively, upon hESC-derived NS/PCs. On
day 14 of differentiation, the EBs expressed not only
markers for the neural progenitors PAX6 and SOX1 but
also additional transcription factors expressed in motor
neuron progenitors, including OLIG2 and NGN2
(Fig. 1c). Subsequently, the EBs were dissociated into
single cells and were adherently differentiated into neu-
rons via monolayer culture in motor neuron medium
(MNM). Within 1 week of adherent differentiation, HB9
and ISL-1, markers for somatic motor neurons, were sig-
nificantly upregulated (Fig. 1c). Consistent with these re-
sults, immunocytochemical analysis revealed the
efficient induction of HB9+/ISL-1+/βIII-Tubulin+ motor
neurons on day 7 of monolayer differentiation (HB9,
49.1 ± 3.3 %, ISL-1, 47.9 ± 2.0 %, n = 3, Fig. 1d, e). Thus,
we have established a rapid, efficient, and simple culture
protocol that achieves motor neuron differentiation in
only 2 weeks.
Effects of long-term hESC-derived motor neuron culture
in vitro
To investigate the effects of the long-term culture of
hESC-derived motor neurons, we examined temporal al-
terations of the expression of several motor neuron
markers during 4 weeks of monolayer differentiation in
MNM. Based on immunocytochemical analysis, the pro-
portion of HB9+ and ISL-1+ cells did not change greatly
and consistently comprised approximately 50–60 % of
the total cells (Fig. 2a, b). By contrast, the proportion of
cells positive for ChAT, a marker of mature motor neu-
rons, was 54.6 ± 4.5 % at the end of one week and in-
creased to 68.1 ± 4.1 % by 4 weeks of monolayer
differentiation. Moreover, after 4 weeks of monolayer
differentiation, the somas of the motor neurons had
grown larger and were stained more clearly for ChAT
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Fig. 1 Rapid, efficient and simple motor neuron differentiation from human pluripotent stem cells. a Schematic presentation of motor neuron
differentiation from hPSCs. b Time-course analysis of the expression of PAX6, SOX1, and NGN2 in EBs via quantitative RT-PCR analysis. Control,
0.09 % DMSO. DS, dorsomorphin and SB431542. DSB, dorsomorphin, SB431542 and BIO. n = 4, mean ± SEM. *, p < 0.05 (Student’s t test). c Time-
course analysis of the expression of PAX6, SOX1, NGN2, OLIG2, NKX2.2, HB9, and ISL-1 mRNA in EBs and during monolayer motor neuron (MN)
differentiation. n = 4, mean ± SEM. d Immunocytochemical analysis of HB9, ISL-1, and βIII-Tubulin 1 week after monolayer differentiation. Scale bar,
100 μm. e Quantitative analysis of the number of the HB9+ and ISL-1+ cells. n = 3, mean ± SEM
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compared with those observed after 1 week of mono-
layer differentiation (Fig. 2a, insets). Quantitative RT-
PCR analysis revealed that the expression of genes
known to be expressed in neural progenitor cells (PAX6,
SOX1, NGN2, OLIG2, and NKX2.2) decreased during
4 weeks of monolayer differentiation, whereas markers
of motor neurons (HB9, ISL-1, and ChAT) were in-
creased during the first 2 weeks of differentiation,
followed by a gradual decrease during the subsequent
2 weeks (Fig. 2c). To address the discrepancy in the time
Fig. 2 Long-term culture of hESC-derived motor neurons. a Immunocytochemical analysis of HB9, ISL-1, βIII-Tubulin, and ChAT after 1, 2, or
4 weeks of monolayer differentiation. Scale bar, 100 μm, and 20 μm (inset). b Quantification of the number of the cells positive for each marker.
n = 4, mean ± SEM. *, p < 0.05 (Student’s t test). c Time-course analysis of the expression of PAX6, SOX1, NGN2, OLIG2, NKX2.2, HB9, ISL-1, and ChAT
during monolayer differentiation via quantitative RT-PCR. n = 4, mean ± SEM. d Western blot analysis of the expression of the HB9, ISL-1, and ChAT
proteins during monolayer differentiation. e Quantitative analysis of the expression of the HB9, ISL-1, and ChAT proteins through densitometry
using ImageJ. The protein expression levels are normalized to β-Actin. n = 4, mean ± SEM. *, p < 0.05, (Student’s t test)
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course of motor neuron marker expression between the
immunocytochemistry and quantitative RT-PCR ana-
lyses, we also performed a western blot analysis (Fig. 2d,
e). We found that the expression of the ChAT protein
significantly increased during 4 weeks of differentiation,
whereas the HB9 protein level was not significantly al-
tered during this period (Fig. 2e). The ISL-1 protein was
significantly decreased during monolayer differentiation
as observed in the quantitative RT-PCR analysis (Fig. 2c).
These results suggest that the expression of HB9 and
ChAT might be regulated post-transcriptionally during
the culture of hESC-derived motor neurons and that
4 weeks of monolayer differentiation facilitates the mat-
uration of hESC-derived motor neurons.
Co-culture with myotubes and the formation of
neuromuscular junctions
To examine the functional properties of hESC-derived
motor neurons, we co-cultured hESC-derived motor neu-
rons with skeletal muscle myotubes derived from the hu-
man myoblast cell line Hu5/E18 [10, 11]. KhES1-derived
EBs containing motor neuron progenitors were partially
dissociated and plated onto human myotubes differenti-
ated from Hu5/E18 in MNM for 3–4 days. hESC-derived
motor neurons labeled with βIII-Tubulin contacted myo-
tubes, formed end plate-like structures, and induced clus-
tering of acetylcholine receptors, which was visualized
using Alexa 555-conjugated α-Bungarotoxin (Alexa 555-
α-BTX) (Fig. 3a, b). These results suggest that motor neu-
rons derived in our system are competent to form func-
tional neuromuscular junctions (NMJs) in vitro.
Differentiation of hiPSCs into motor neurons
We further examined whether this motor neuron differ-
entiation system is applicable to hiPSCs. Three hiPSC
clones (201B7, TIGE-9, and YFE-16) were differentiated
into motor neurons following the same protocol (Fig. 4).
201B7 was kindly provided by Dr. Yamanaka [1], and
TIGE-9 and YFE-16 were established in our laboratory
from fibroblasts from adult males (36 and 24 years of
age, respectively) by introducing OCT4, SOX2, KLF4, L-
MYC, LIN28, and shTP53 via episomal vectors; the last
two clones were subjected to analysis of pluripotent
marker expression via immunocytochemistry and quan-
titative RT-PCR, silencing of episomal transgenes, karyo-
type analysis, and teratoma formation capacity testing
(Additional file 1: Figure S1). All of these clones effi-
ciently differentiated into HB9+ and ISL-1+ motor neu-
rons that expressed the mature motor neuron marker
ChAT by 4 weeks of monolayer differentiation (Fig. 4a).
The proportions of HB9+ and ISL-1+ cells 1 week after
monolayer differentiation of dissociated EBs derived
from the three hiPSC clones were similar to those ob-
tained from KhES1 hESCs, at approximately 40-50 %
(Fig. 4b). We also examined the time course of motor
neuron marker expression via quantitative RT-PCR and
western blotting and confirmed similar expression pro-
files in all of the hiPSC clones to those observed in
KhES1 cells (Fig. 4c-e). These results suggest that our
differentiation protocol is applicable to hiPSCs, thereby
minimizing clonal variation among the hPSC clones.
Replacement of small-molecule compounds by more
specific and less toxic inhibitors
Although our differentiation protocol achieved rapid and
efficient differentiation of motor neurons from hPSCs,
we observed significant cell death during EB formation
after the addition of 3 compounds (DSB), which may
have been caused by the cytotoxicity of the small-
molecule compounds (Fig. 5a). To avoid this massive cell
death and more efficiently obtain motor neuron progeni-
tors for further analysis, we examined the effects of
other compounds that inhibit BMP and GSK3β on the
differentiation of 201B7 iPSCs. We first replaced BIO
with CHIR99021, a more specific and less toxic inhibitor
Fig. 3 Co-culture of hESC-derived motor neurons with myotubes. a
Motor neurons derived from KhES1 cells were plated on myotubes de-
rived from the human myoblast cell line Hu5/E18 to form end plate-
like structures. Scale bar, 20 μm. b Immunocytochemical analysis of
βIII-Tubulin and MyHC after 3 days of co-culture with motor neurons
and myotubes. AChR clusters were visualized with Alexa 555-
conjugated α-Bungarotoxin (α-BTX, white allows). Scale bar, 50 μm
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Fig. 4 Derivation of motor neurons from hiPSCs. a Immunocytochemical analysis of motor neurons derived from 201B7, TIGE-9 and YFE-16 for HB9,
ISL-1, and βIII-Tubulin after 2 weeks of monolayer differentiation and ChAT after 4 weeks of monolayer differentiation. Scale bar, 100 μm. b Quantitative
analysis of the number of the cells positive for motor neuron markers in cultures derived from each hiPSC clone. n = 3, mean ± SEM. c Time-course
analysis of the expression of HB9, ISL-1, and ChAT during monolayer differentiation of hiPSC-derived motor neurons via quantitative RT-PCR. n = 3,
mean ± SEM. d Western blot analysis of the expression of the HB9, ISL-1, and ChAT proteins during monolayer differentiation of hiPSC-derived motor
neurons. B7, 201B7. T9, TIGE-9. Y16, YFE-16. e Quantitative analysis of the expression of the HB9, ISL-1, and ChAT proteins through densitometry using
ImageJ. Protein expression levels are normalized to β-Actin. n = 3, mean ± SEM. *, p < 0.05, (Student’s t test)
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Fig. 5 (See legend on next page.)
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of GSK3β [12], and observed a significant reduction in
cell death during EB formation (Fig. 5a). Treatment of
EBs with CHIR99021 in combination with DS (DSC) re-
sulted in a 1.79 ± 0.50-fold increase in the cell number
obtained from EBs after 14 days of differentiation com-
pared with those treated with DSB (Fig. 5b). We also ex-
amined the effects of LDN193189, a more specific and
less toxic inhibitor of BMP signals [13]. When EBs were
treated with LDN193189, SB4315342, and CHIR99021
(LSC), we observed a 1.54 ± 0.43-fold increase in the
number of cells obtained from EBs after 14 days of dif-
ferentiation compared with those treated with DSC, but
the difference was not statistically significant (Fig. 5c).
No significant differences in the differentiation of motor
neurons were observed among the populations subjected
to the DSB, DSC, and LSC treatments. The proportions
of HB9+ motor neurons under DSC and LSC conditions
were 37.9 ± 3.4 and 39.4 ± 1.1 %, respectively (Fig. 5d, e),
and the results of time-course analysis of the expression
of motor neuron markers did not differ significantly
among the DSB, DSC, and LSC treatments (Fig. 4a, b
and 5d, e). Together, these results suggest that both the
DSC and LSC protocols are useful in practice for obtain-
ing a greater number of motor neuron progenitors and
that the inhibition of BMP and TGFβ signals combined
with inhibition of GSK3β, which activates canonical
WNT signaling, have positive effects on the induction of
neural progenitors, excluding the off-target effects of
these compounds.
Visualization of motor neurons using an HB9e438::Venus
reporter lentivirus
Although our method achieved efficient motor neuron
derivation, the proportion of HB9+ motor neurons was
approximately 40–50 %, and other cell types persisted in
culture, presenting an obstacle for the analysis of motor
neuron-specific biological events. To address these is-
sues, we constructed an HB9e438::Venus reporter lenti-
virus, in which the Venus fluorescent protein (an altered
yellow fluorescent protein; [14]) is expressed under the
control of the 438-base pair HB9 enhancer element
(HB9e438, [15]) and the human β-globin minimal pro-
moter. After 3–4 days of monolayer differentiation,
KhES1-derived motor neurons were infected with the
HB9e438::Venus reporter lentivirus and were observed to
extend Venus+ neurites 24 h after lentivirus infection
(Fig. 6a). At one, two, or four weeks after lentivirus in-
fection, cells were fixed and subjected to immunocyto-
chemistry to detect HB9 and Venus (using an anti-GFP
antibody) (Fig. 6b). Most Venus+ cells were also posi-
tive for HB9 one week after lentiviral infection (HB9/
Venus = 84.1 ± 2.4 %, Fig. 6c), suggesting that the ex-
pression of the Venus fluorescent protein accurately
reflects HB9 expression. Many cells were also positive
for another motor neuron marker, ISL-1, after 1 week
(ISL-1/Venus = 39.5 ± 13.2 %, Fig. 6c). Moreover, after
4 weeks of monolayer differentiation, most Venus+ cells
were also positive for ChAT (ChAT/Venus = 83.4 ± 1.7 %,
Fig. 6c). These results suggest that the HB9e438::Venus
lentivirus reporter allows accurate visualization of live
motor neurons derived from hPSCs.
To further confirm the relevance of this reporter, we
examined the expression of the HB9e438::Venus lentivirus
through fluorescence-activated cell sorting (FACS) one
week after the infection of 201B7-derived motor neu-
rons. We divided the cells into 4 fractions: a negative
fraction (gated by the fluorescence intensity of unin-
fected controls, gray peak) and 3 positive fractions
(green peak), where the positive cells were equally subdi-
vided into low-positive, middle-positive, and high-
positive fractions (Fig. 6d). The cells in each of the 4
fractions were sorted and subjected to quantitative RT-
PCR analysis to detect the expression of Venus mRNA
and the motor neuron markers HB9, ISL-1, and ChAT
(Fig. 6e). We observed a significant increase in the ex-
pression of Venus, HB9, and ISL-1 in the high-positive
fraction (p < 0.05, Kruskal-Wallis test) and a tendency
for the expression of ChAT to increase. The expression
levels of HB9 and ISL-1 in the high-positive fraction
were 12.4 ± 5.4-fold and 6.4 ± 2.6-fold higher than in the
negative fraction. We also examined the expression of
Venus fluorescent protein from a reporter lentivirus
containing the same vector backbone, but without the
HB9e438 enhancer element (background reporter lenti-
virus; Yellow peak in Fig. 6d), and found that the fluor-
escence observed in the high-positive fraction of
HB9e438::Venus reporter-transduced cells overlapped
minimally with the fluorescence generated by the
(See figure on previous page.)
Fig. 5 Replacement of small molecule compounds with more specific and less toxic inhibitors. a Morphology of EBs, which were derived from
201B7, treated with vehicle (DMSO), DS, DSB, or DSC on day 4. Massive cell death was observed after the treatment of DSB. Scale bar = 200 μm.
Control, 0.09 % DMSO. DS, dorsomorphin and SB431542. DSB, dorsomorphin, SB431542, and BIO. DSC, dorsomorphin, SB431542, and CHIR99021.
b The number of cells harvested from DSB- and DSC-treated EBs on day 14 per 100-mm culture dish of starting hiPSCs. n = 4, mean ± SEM. *,
p < 0.05 (Student’s t test). c The number of cells harvested from DSC- and LSC-treated EBs on day 14 per 100-mm culture dish of starting hiPSCs.
n = 4, mean ± SEM. LSC, LDN193189, SB431542, and CHIR99021. d Immunocytochemical analysis of motor neurons derived from DSC- or LSC-
treated EBs for HB9, ISL-1 and βIII-Tubulin on day 7 of monolayer differentiation. Scale bar, 100 μm. d Quantitative analysis of the number of the
cells positive for HB9 and ISL-1. n = 4, mean ± SEM. e Time-course analysis of the expression of PAX6, SOX1, NGN2, OLIG2, NKX2.2, HB9, and ISL-1 in
EBs and during monolayer differentiation of motor neurons (MN) via quantitative RT-PCR. n = 4, mean ± SEM
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Fig. 6 (See legend on next page.)
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background reporter. Together, these results suggested
that the high-positive fraction was a bona fide “motor
neuron fraction” and that this approach can be used for
the purification of hPSC-derived motor neurons.
Discussion
Rapid and efficient motor neuron induction from hiPSCs
In this report, we have demonstrated a protocol for ef-
fective and reproducible motor neuron derivation that
does not require transgene expression. Although hESCs
and hiPSCs have been differentiated into HB9+, ISL-1+,
and ChAT+ motor neurons in several previous studies,
our method of motor neuron derivation is superior for
the following three reasons: 1) its short culture period
and simple culture method; 2) the high purity of the
HB9+ motor neurons obtained; and 3) its reproducibility
among several hPSC lines, thereby minimizing clonal
variation. One previously reported method for deriving
motor neurons from hPSCs is based on the serum-free
floating culture of EB-like aggregates with quick reaggre-
gation (SFEBq) method [2, 16]. Although this method is
widely known, it requires 35 days, and the procedure is
complicated. Moreover, while the purity of SMI-32+
motor neurons derived from 201B7 iPSCs was 35 %, the
purity of other iPSC clones was only 15-30 %, with sig-
nificant variability. Several methods have been estab-
lished in previous studies to improve the efficiency of
motor neuron derivation. For example, a method involv-
ing dual SMAD inhibition, using dorsomorphin and
SB431542, enabled the production of over 50 % pure
HB9+ motor neurons, but induction of these motor neu-
rons required approximately 30 days [17, 18]. In other
studies, motor neurons were induced within 20–25 days,
but the purity of HB9+ cells was only 20–30 % [19, 20].
In the present study, we derived 40–50 % pure HB9+
motor neurons within 2 weeks, achieving a high effi-
ciency within a short culture period. In addition, the
efficiency of motor neuron derivation was consistently
40–50 % among several hPSC clones. Therefore, we have
overcome the issue of clonal variation among hiPSC
clones [5] and established a more stable in vitro model
for the pathophysiological analysis of motor neuron
diseases.
GSK3β inhibitor treatment enhances neural induction
In this study, rapid and efficient neural induction was
achieved by treating cells with BIO or CHIR99021 in
addition to dual SMAD inhibition at an early stage of
differentiation. GSK3β inhibitors such as BIO and
CHIR99021 have recently been used for neural induction
[3, 18, 21]. However, the effects of GSK3β inhibitors
have not been discussed in detail. We examined the dif-
ference in gene expression following “DS” and “DSB”
treatments and found that PAX6, SOX1, and NGN2 were
upregulated by BIO. β-catenin, which is stabilized by the
GSK3β inhibitor BIO, is reported to form a complex
with TCF1 and to directly promote the transcription of
PAX6, SOX1, and NGN2 [22]. In addition, β-catenin is
known to form a complex with the intracellular domain
of Notch and enhances HES1 expression, which in turn
promotes the proliferation of NS/PCs and inhibits the
differentiation of NS/PCs [23]. Thus, the activation of
Wnt/β-catenin signaling by GSK3β inhibition may dir-
ectly enhance the transcription of genes associated
with the initial steps of neural induction and may also
promote the proliferation of induced NS/PCs in our
culture system.
Effect of long-term monolayer culture on the maturation
of motor neurons
Cell maturation is particularly important in pathological
models of late-onset disease because the cells derived
from hPSCs are often immature and do not recapitulate
disease phenotypes. In one previous report, more than
100 days of monolayer differentiation were required to
detect an apparent phenotype in neurons derived from
disease-specific hiPSCs [24]. To recapitulate aging in
iPSC-derived neurons, forced expression of Progerin,
which is known to enhance cellular aging, was per-
formed to detect the phenotypes of the diseased neurons
[25]. Moreover, the recapitulation of cellular stress in
vivo using glutamate or endoplasmic reticulum (ER)
stress driven by tunicamycin has been employed to
examine the pathology of neurons or glial cells derived
from disease-specific hiPSCs [26, 27]. By contrast, a de-
tailed time-course analysis of gene expression during
motor neuron differentiation and the relationship
(See figure on previous page.)
Fig. 6 Visualization of motor neurons using the HB9e438::Venus reporter lentivirus. a Live-cell imaging of HB9e438::Venus+ motor neurons 3 days
after lentivirus infection. Scale bar, 100 µm. b Immunocytochemical analysis of motor neurons for HB9, ISL-1, ChAT, and Venus (GFP antibody) at
1, 2, and 4 weeks after HB9e438::Venus lentivirus infection. Scale bar, 100 μm. c Quantitative analysis of the number of cells positive for HB9, ISL-1,
and ChAT among Venus+ cells. n = 4, mean ± SEM.*, p < 0.05 (Student’s t test) d Histograms of HB9483::Venus lentivirus-infected cells (Green),
background lentivirus (β-glo::Venus)-infected cells (Yellow), and uninfected control cells (Gray) via flow cytometry. The HB9e438::Venus+ cells were
divided into 4 fractions: a negative fraction (Neg), in which the fluorescence intensities were equivalent to an uninfected negative control, and a
low-positive fraction (Low), a middle-positive fraction (Middle), and a high-positive fraction (High), in which the fluorescence intensities were
equivalent to the lowest 1/3, the next lowest 1/3, and the highest 1/3 of fluorescence intensities within the positive fraction, respectively. e The
expression of Venus, ISL-1, HB9, and ChAT in each fraction determined via quantitative RT-PCR. n = 3, mean ± SEM. A significant increase in the
expression of Venus, HB9, and ISL-1 in the high-positive fraction was observed (p < 0.05, Kruskal-Wallis test)
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between the length of the culture period and the matur-
ation of motor neurons remains to be reported. We
found that the expression of the ChAT protein was up-
regulated, and the soma of motor neurons became larger
and was more clearly stained for ChAT over the course
of four weeks of monolayer differentiation, suggesting
that motor neurons matured over this time in vitro [28].
Thus, a 4 week period of monolayer differentiation is re-
quired for the maturation of hPSC-derived motor neu-
rons. Further improvements of culture conditions for
maturing motor neurons are expected in future studies.
In this study, we found that HB9 and ChAT protein
were unchanged or upregulated, though HB9 mRNA
and ChAT mRNA was decreased after 2 weeks of mono-
layer differentiation. This discrepancy may be attribut-
able to post-transcriptional regulations of these genes
during the maturation of motor neurons. In the process
of neural differentiation, post-transcriptional regulations
are known to play important roles to determine cell fates
or behaviors. For instance, ubiquitin specific protease 7
(USP7) deubiquitinates RE1-silencing transcription factor
(REST) protein and maintain its protein expression to
keep stemness of NS/PCs [29]. For another example, the
translation of FoxP1 in motor neuron progenitors in chick
is suppressed by miR-9 and promotes their differentiation
into the neurons in medium motor columns via the in-
crease of Hb9 and Lhx3 and the decrease of Isl-1 [30]. In
the developing human neocortex, the translation of Nitric
oxide synthase 1 (NOS1) mRNA is temporally and region-
ally regulated by the expression of Fragile X mental re-
tardation protein (FMRP), which is expressed only in
pyramidal neurons during early synaptogenesis, though
NOS1 mRNA is widely expressed [31]. Moreover, in the
axonal terminal of mature neurons, the expression of De-
leted in colorectal carcinoma (DCC) proteins depends on
the regulation of local translation to quickly respond to
exogenous signals [32]. Considering these region- and
stage-specific post-transcriptional regulations, the mis-
match between mRNA and protein expression of HB9
and ChAT in the present study may be attributable to
such post-transcriptional regulations, which may have im-
portant roles in the differentiation or the maturation of
PSC-derived motor neurons.
In contrast to the sustained expressions of HB9 and
ChAT proteins, both ISL-1 mRNA and ISL-1 protein
were significantly decreased after 2 weeks of monolayer
differentiation, but the number of ISL-1+ cells was not
significantly decreased (Fig. 2b). Considering the repro-
ducibility of these results in several hPSC clones, KhES1,
201B7, TIGE-9, and YFE-16 (Figs. 2e, 4e), these results
suggest that the expression of ISL-1 per motor neurons
decreases as the maturation progressed. Because precise
expression of ISL-1 during the maturation of motor neu-
rons has never been discussed in detail so far, the
regulation and the biological significance of the expres-
sion of ISL-1 should be clarified in the future.
The HB9e438::Venus reporter lentivirus is a useful fluorescent
probe for visualizing and purifying HB9+ motor neurons
hPSC-derived motor neurons are usually mixed with
non-motor neurons following differentiation. They must
therefore be identified and purified prior to the examin-
ation of motor neuron-specific pathogenesis. For the
analysis of multiple hiPSC clones for the purpose of re-
producibility, direct labeling of hPSC-derived motor
neurons by a lentiviral reporter is an easy and efficient
method. In an initial report, 9 kb of the 5′ upstream re-
gion of the HB9 gene, including the HB9 enhancer/pro-
moter element, was identified and has since been widely
used to visualize HB9+ motor neurons [33]. Subse-
quently, it was determined that the 5′ 3.6 kb fragment
of this 9 kb element is necessary and sufficient for the
transcription of HB9 in mice, especially the 438-bp or
125-bp enhancer elements containing Pdx and Hox
binding domains [15]. Therefore, to construct an effi-
cient reporter system for HB9, we generated a reporter
lentivirus that expresses the Venus fluorescent protein
under the control of the 438-bp HB9 enhancer element
and the β-globin minimal promoter (HB9e438::Venus),
which has been shown to specifically label hPSC-derived
HB9+ motor neurons with more than 80 % accuracy via
immunocytochemistry (Fig. 6c). Although this reporter
system exhibits some background signal, possibly due to
the background activity of the β-globin minimal pro-
moter, gating our analysis to the high-positive fraction,
consisting of the top 1/3 fraction of HB9::Venus+ cells,
enabled us to obtain bona fide HB9+ motor neurons
(Fig. 6d). Thus, this reporter system allows accurate
visualization and purification of hPSC-derived motor
neurons and permits us to perform motor neuron-
specific analysis, yielding a powerful tool for the patho-
physiological analysis of disease-specific motor neurons.
Conclusions
We established a rapid, efficient and simple method for
motor neuron differentiation from hPSCs. We also visu-
alized motor neurons using an HB9 reporter lentivirus
(HB9e438::Venus). These techniques can be applied to the
effective pathophysiological analysis of motor neuron
diseases using disease-specific iPSCs.
Materials and methods
Isolation of human skin fibroblasts and generation of
hiPSCs
Human dermal fibroblasts (HDFs) were obtained from a
24-year-old Japanese male via skin punch biopsy (YF-
HDF) and from a 36-year-old Japanese male from the
Japanese Collection of Research Bioresources (JCRB)
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Cell Bank (TIG114-HDF). HDFs were cultured in
DMEM (Sigma-Aldrich, St Louis, MO, USA), 10 % fetal
bovine serum (FBS; Sigma-Aldrich, St Louis, MO, USA),
2 mM L-glutamine, and 1 % penicillin/streptomycin.
Then, 6×105 HDFs were transfected with 1 μg of each of
pCXLE-hOCT3/4-shp53 (OCT4 and shTP53), pCXLE-
hSK (SOX2 and KLF4) and pCXLE-hUL (L-MYC and
LIN28; a gift from Dr. Yamanaka) [34]. Plasmid transfec-
tion was performed using the Neon transfection system
(Thermo Fisher Scientific, USA). After 6 days, the cells were
harvested and plated on mitomycin-C-treated SNL murine
fibroblast feeder cells in 0.1 % gelatin-coated tissue culture
dishes in human fibroblast medium. On the next day, the
medium was changed to standard hESC medium containing
DMEM/F-12 (Wako, Japan), 20 % knock out serum replace-
ment (KSR) (Thermo Fisher Scientific, USA), 2 mM L-glu-
tamine, 1 % non-essential amino acids (NEAA) (Sigma-
Aldrich, USA), 0.1 mM 2-melchaptethanol (2-ME) (Sigma-
Aldrich, USA), 0.5 % penicillin/streptomycin and 4 ng/mL
recombinant human fibroblast growth factor-2 (FGF-2)
(Peprotech, USA). When the colonies were sufficiently large
in size, they were picked and expanded in the same way as
hESCs. The properties of the established hiPSC clones
were evaluated as described previously (Additional file 1:
Figure S1) [34]. hiPSC clones YFE-16 and TIGE-9 were
established from YF-HDF and TIG114-HDF, respectively.
All of the experimental procedures for hiPSC produc-
tion were approved by the ethics committee of the Keio
University School of Medicine (approval number
20080016) and the ethics committee of the Aichi Med-
ical University School of Medicine (approval number
14–004). All of the experimental procedures for human
embryonic stem cell culture were approved by the ethics
committee of the Keio University School of Medicine
(approval number 2002–001).
hESC and hiPSC culture and differentiation in vitro
KhES1 (a gift from Dr. Norio Nakatsuji) [9], 201B7 (a gift
from Dr. Shinya Yamanaka) [1], TIGE-9, and YFE-16 cells
were maintained on mitomycin-C-treated SNL murine
fibroblast feeder cells or mouse embryonic fibroblasts
(MEFs) in 0.1 % gelatin-coated tissue culture dishes in
hESC medium and were used for motor neuron induction.
For differentiation, hESC/hiPSC colonies were detached
using a dissociation solution containing 0.25 % trypsin,
100 μg/ml collagenase IV (Invitrogen, 17104–019), 1 mM
CaCl2, and 20 % KSR and cultured in suspension in bac-
teriological dishes in standard hESC medium without FGF-
2, after the removal of SNL feeder cells, with incubation
for 1–2 h in gelatin-coated dishes. On day 1, the medium
was changed to human embryoid body (hEB) medium con-
taining DMEM/F-12, 5 % KSR, 2 mM L-glutamine, 1 %
NEAA, and 0.1 mM 2-ME with 3 μM dorsomorphin dihy-
drochloride (Santa Cruz, USA), 3 μM SB431542 (Santa
Cruz, USA), and 3 μM BIO (Sigma-Aldrich, USA). On day
2, the medium was changed to new hEB medium contain-
ing 3 μM dorsomorphin dihydrochloride, 3 μM SB431542,
3 μM BIO, and 1 μM retinoic acid (RA) (Sigma-Aldrich,
USA). From day 4 to day 14, hEBs were cultured in hEB
medium containing 1 μM RA and 1 μM purmorphamine
(Calbiochem, Germany), and the medium was changed
every 2–3 days. On day 14, hEBs were enzymatically disso-
ciated into single cells using TrypLE Select (Thermo Fisher
Scientific, USA). The dissociated cells were plated on re-
combinant mouse Laminin (Thermo Fisher Scientific,
USA)-coated dishes at a density of 5×104–1×105 cells/cm2
and cultured in motor neuron medium (MNM) consisting
of media hormone mix (MHM) or KBM Neural Stem
medium (Kohjin Bio, Japan) [6] supplemented with 2 % B27
supplement (Thermo Fisher Scientific, USA), 1 % NEAA, 50
nM RA, 500 nM purmorphamine, 10 μM cyclic AMP
(cAMP) (Sigma-Aldrich, USA), 10 ng/mL recombinant
BDNF (R&D systems, USA), 10 ng/mL recombinant GDNF
(R&D systems, USA), 10 ng/mL recombinant human IGF-1
(R&D systems, USA) and 200 ng/mL L-ascorbic acid
(Sigma-Aldrich, USA) for 1, 2, or 4 weeks (i.e., 21, 28, or
42 days from EB formation). Half of the medium was chan-
ged every 2–3 days.
Generation of the HB9e438::Venus lentivirus and visualization
of HB9+ motor neurons
HEK293T cells cultured in the Freestyle 293 expression
medium (Thermo Fisher Scientific, USA) in 150 mm dishes
were transfected with 30 μg of pSIN2-HB9e438-βglo-Venus
and 20 μg of each of two packaging vectors (pCMV-VSV-G
and pCAG-HIV-gp, kindly provided by Dr. Hiroyuki
Miyoshi) in 280 μL of Gene Juice (Novagen, USA), and the
medium was changed the next day. Three days after the
medium change, the culture supernatant was harvested and
centrifuged at 25,000 rpm for 90 min at 4 °C in an Optima
LE-80 K ultracentrifuge (Beckman Coulter, USA). After dis-
carding the supernatant, 80 μL of PBS/150 mm dish was
added to the pellet, which was resuspended by repeated
pipetting to obtain the HB9e438::Venus reporter lentivirus.
Lentiviral infection was performed on day 3 or 4 of
monolayer motor neuron differentiation. For lentiviral in-
fection, HB9e438::Venus in Opti-MEM (Thermo Fisher Sci-
entific, USA) was added to a motor neuron culture,
followed by incubation for 2 h, after which the total
medium was changed to MNM. The cells were cultured
for 1, 2, or 4 weeks (i.e., 24, 31, or 45 days after EB forma-
tion) and used for subsequent analyses.
Hu5/E18 culture, differentiation and co-culture with
motor neurons
The human myoblast cell line Hu5/E18 was cultured in
collagen type I-coated 10-cm dishes (Iwaki, Japan) or Cell-
matrix type I-P (Nitta gelatin, Japan) -coated dishes in
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myoblast medium containing DMEM, 20 % FBS, 2 mM L-
glutamine, 0.5 % penicillin/streptomycin and 2 % Ultroser
G serum substitute (Pall, France). For in vitro neuro-
muscular co-culture, Hu5/E18 cells were plated at a dens-
ity of 1×103 cells/ml on a Cellmatrix type I-P-coated mi-
cro cover glass (Matsunami, Japan) and cultured until the
cells reached approximately 50 % confluence. Then, the
medium was changed to MNM, and the cells were
cultured for 4 additional days, until the formation of
myotubes. Partially dissociated EBs derived from
KhES1 cells were plated onto Hu5/E18-derived myo-
tubes at a density of 2.5×102–5×103 cells/cm2 and co-
cultured with the myotubes for 3–4 days in MNM.
RNA isolation and quantitative RT-PCR analysis
RNA was isolated using an RNeasy mini kit (Qiagen,
Germany) and then converted into cDNA using Super-
Script III reverse transcriptase (Thermo Fisher Scientific,
USA) and Oligo dT primers as described previously [35].
Quantitative RT-PCR analysis was performed using
SYBR premix ex Taq II (Takara, Japan) and the
Mx3000P (Stratagene, USA), Step One Plus, or ViiA7
real-time PCR system (Applied Biosystems, USA). The
amount of cDNA was normalized to that of human-
specific β-ACTIN mRNA. The sequences of the primers
and the corresponding cycling conditions are described
in Table 1.
Immunocytochemistry
Cells were fixed in 4 % paraformaldehyde for 15–25 min
at room temperature. After blocking in blocking buffer
(PBS containing 5 FBS and 0.3 % Triton X-100), the cells
were incubated with primary antibodies overnight at 4 °C.
The cells were then rinsed with PBS three times and incu-
bated with Alexa 488-, Alexa 555-, or Alexa 647-
conjugated secondary antibodies (Thermo) for 1 h at
room temperature. Nuclei were stained with 10 μg/ml
Hoechst 33258 (Sigma-Aldrich, USA). The cells were then
rinsed with PBS three times, mounted on slides and exam-
ined using a universal fluorescence microscope (Axio-
photo, Carl Zeiss, Germany) or confocal laser-scanning
microscope (LSM700, Carl Zeiss, Germany). The primary
antibodies used in these analyses were as follows: HB9
(mouse IgG1, 1:200, Developmental Studies Hybridoma
Bank [DSHB], USA), ISL-1 (mouse IgG2a, 1:200, DSHB,
USA), βIII-Tubulin (mouse IgG2b, 1:4000, Sigma-Aldrich,
USA or rabbit IgG, 1:4000, Biolegend, USA), ChAT (goat
IgG, 1:200, Millipore, USA), GFP (rabbit IgG, 1:200, MBL,
USA), and MyHC (mouse IgG2b, 1:200, DSHB, USA). For
the observation of n-AChR clusterization, Alexa fluor
555-conjugated α-Bungarotoxin, (1 μg/mL, Invitrogen,
USA) was added to samples and incubated for 1 h.
Western blot analysis
Western blot analysis was performed as previously reported.
A protein sample from a total cell extract (10 μg) was run
Table 1 Primer sequences and cycling conditions for quantitative RT-PCR analysis




SOX1 hSOC1-S3755 GAAATAGCCAATGCCAGGTG hSOX1-AS4039 CCGTGAATACGATGAGTGTTACC 285 62 -
PAX6 hPAX6-S421 TAGGGGCGCGCAGATGTGTG hPAX6-AS538 TGCATGCTGGCTCTGGCTGG 118 68 -
OLIG2 hOLIG2-S49 GTTCTCCCCTGAGGCTTTTC hOLIG2-AS223 AGAAAAAGGTCATCGGGCTC 175 67 -
NKX2.2 hNKX2.2-S434 GCTCTGTGGCCGAAGGTCCG hNKX2.2-AS657 GCTTGAGTCCTGAGGGGGCG 224 62 -
ISL-1 hISL1-S1294 AGCAGCCCAATGACAAAACT hISL1-AS1494 CTGAAAAATTGACCAGTTGCTG 201 60 -
HB9 hHB9-S951 GTCCACCGCGGGCATGATCC hHB9-AS1162 TCTTCACCTGGGTCTCGGTGAGC 212 62 -
CHAT hChAT-S1360 GGAGGCGTGGAGCTCAGCGACACC hChAT-AS1592 CGGGGAGCTCGCTGACGGAGTCTG 256 62 -
NGN2 hNGN2-S93 AGACACGCACCACCACCACAACAC hNGN2-AS293 TGACTTTGGCCTGTGCCGGGAATC 201 60 +
EBNA-1 tg EBNA-1-S ATCAGGGCCAAGACATAGAGATG EBNA-1-AS GCCAATGCAACTTGGACGTT 61 60 -
NANOG total hNANOG-S286 CCTATGCCTGTGATTTGTGG hNANOG-AS503 TGTTTCTTGACTGGGACCTTG 218 62 -
OCT4 total hPOU5F1-S1165 GACAGGGGGAGGGGAGGAGCTAGG hPOU5F1-
AS1283
CTTCCCTCCAACCAGTTGCCCCAAAC 144 62 -
OCT4 tg hPOU5F1-pla-S CATTCAAACTGAGGTAAGGG hPOU5F1-pla-AS TAGCGTAAAAGGAGCAACATAG 124 62 -
SOX2 tg hSOX2-pla-S TTCACATGTCCCAGCACTACCAGA hSOX2-pla-AS TTTGTTTGACAGGAGCGACAAT 111 62 -
KLF4 tg hKLF4-pla-S CCACCTCGCCTTACACATGAAGA hKLF4-pla-AS TAGCGTAAAAGGAGCAACATAG 156 62 -
L-MYC tg hL-MYC-pla-S GGCTGAGAAGAGGATGGCTAC hL-MYC-pla-AS TTTGTTTGACAGGAGCGACAAT 122 62 -






GGGTGTAACGCAACTAAGTCA 180 62 -
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on 10 % SDS-PAGE and transferred to a nitrocellulose
membrane. The blot was then probed with the following
primary antibodies: β-ACTIN (mouse IgG1, 1:5000, Sigma-
Aldrich, USA), HB9 (mouse IgG1, 1:2000, DSHB, USA),
ISL-1 (mouse IgG2a, 1:2000, DSHB, USA), and ChAT (goat
IgG, 1:2000, Chemicon, USA). Signals were detected with
HRP-conjugated secondary antibodies (Jackson ImmunoRe-
search laboratory Inc., USA) using an ECL Prime kit (Amer-
sham Biosciences, USA). Quantitative analysis was
performed using LAS4000 (Amersham biosciences, USA)
and ImageJ software. The amount of protein loaded in each
slot was normalized to β-ACTIN.
Flow cytometry
For flow cytometric analysis, 201B7-derived motor neurons
were harvested 7 days after infection with the HB9e438::Ve-
nus lentivirus (10–11 days of monolayer differentiation)
using TrypLE Select. The dissociated cells (5×104–1×105
cells) were suspended in 50–100 μl of Hanks’ balanced salt
solution (HBSS) (Thermo Fisher Scientific, USA) contain-
ing 2 % fetal bovine serum, 10 mM HEPES, and 1 μg/ml
propidium iodide. The cells were then analyzed and sorted
based on the expression of the HB9e438::Venus reporter
using a FACS Aria III cell sorter (BD Biosciences, USA).
Teratoma formation assay
TIGE-9 and YFE-16 iPSCs were harvested in dissoci-
ation solution, collected into tubes, and centrifuged, and
the resulting pellets were suspended in hESC medium
with 10 μΜ Y-27632 (Wako, Japan), a Rho-associated
coiled-coil forming kinase (ROCK) inhibitor. Then,
1×105–5×105 cells were injected into the testes of NOD/
SCID mice (Charles River, USA). At 8–10 weeks after in-
jection, the tumors were dissected and fixed with PBS
containing 4 % PFA. Paraffin-embedded tissue was sliced
and stained with hematoxylin and eosin.
Additional file
Additional file 1: Figure S1. Evaluation of hiPSCs, TIGE-9 and YFE-16
cells. a The genomic integration of episomal vectors was detected
through quantitative genomic PCR with primers specific for EBNA-1.
EBNA-1 copy numbers are normalized to the β-ACTIN copy number. The
EBNA-1 copy numbers were presented as the relative copy numbers to
those in fibroblasts transfected with three plasmid vectors for reprogramming
and cultured for 6 days (fibroblast-TF day6) (see Materials and methods). b
Transgene expression in established hiPSC clones was examined via
quantitative RT-PCR and is presented as the copy number normalized
to that of β-ACTIN. The expressions of indicated genes are presented
as the relative expressions to those in fibroblast-TF day6. c The
expression levels of the pluripotency markers OCT4 and NANOG in
established hiPSC clones were determined through quantitative RT-
PCR analysis. d Immunocytochemical analysis of TIGE-9 and YFE-16
hiPSCs for OCT4, NANOG, Tra-1–60, and SSEA-4. Scale bar, 300 μm. e
Hematoxylin and eosin staining of teratomas derived from TIGE-9 and
YFE-16 hiPSCs. Scale bar, 200 μm. f Karyotype analysis of TIGE-9 and
YFE-16 hiPSCs via G-banding analysis. (PNG 5285 kb)
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